Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shockwave Medical is a pioneering medical technology company that specializes in the treatment of calcified cardiovascular disease through its proprietary Intravascular Lithotripsy (IVL) technology. The company's IVL system utilizes sonic pressure waves to safely crack calcium deposits within the arterial wall, restoring vessel compliance and improving the outcomes of subsequent stenting and angioplasty procedures. Shockwave's commercial portfolio includes specialized catheters for both coronary and peripheral artery diseases, such as the Shockwave C2+ and M5+ systems. In May 2024, the company was acquired by Johnson & Johnson for approximately $13.1 billion, becoming a cornerstone of J&J's MedTech cardiovascular division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shockwave Technical Service.